In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Bioscrip Inc. (NASDAQ:BIOS) reported that Ares Management Llc. has picked up 10,767,555 of common stock as of 2017-07-10.
The acquisition brings the aggregate amount owned by Ares Management Llc. to a total of 10,767,555 representing a 8.2% stake in the company.
For those not familiar with the company, BioScrip, Inc. is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. The Company operates through Infusion Services segment. The Company operates through approximately 70 service locations in over 30 states. The Company offers home infusion services to provide clinical management services and the delivery of prescription medications. The Company provides services in coordination with, and under the direction of, the patient’s physician. The Company’s multidisciplinary team of clinicians, including pharmacists, nurses, dietitians and respiratory therapists, work with the physician to develop a plan of care suited to the patient’s specific needs. Its platform provides service capabilities to deliver clinical management services that offer patients a community-based and home-based care environment.
A glance at Bioscrip Inc. (NASDAQ:BIOS)’s key stats reveals a current market capitalization of $318.29 Million based on $120.98 Million shares outstanding and a price at last close of $2.68 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-06-24, Kreger picked up 10,000 at a purchase price of $1.32. This brings their total holding to 22,628 as of the date of the filing.
On the sell side, the most recent transaction saw Holubiak unload 5,000 shares at a sale price of $7.94. This brings their total holding to 40,000.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Bioscrip Inc. (NASDAQ:BIOS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.